Showing results (111-120 of 156) with videos related to
Sort By:
Pageof 16
European Journal of Medicinal Chemistry|March 29, 2011
Synthesis of 1-naphtylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agentsFerdinando Fiorino, Elisa Magli, Elisa Perissutti, et al.Journal of Cancer Research and Clinical Oncology|July 27, 2019
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastomaFrancesco Marampon, Flavio Leoni, Andrea Mancini, et al.Journal of Cancer Research and Clinical Oncology|November 27, 2018
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastomaFrancesco Marampon, Flavio Leoni, Andrea Mancini, et al.Cells|April 30, 2020
Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in ChondrosarcomaMichele Minopoli, Sabrina Sarno, Gioconda Di Carluccio, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2019
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal CancerAntonio Avallone, Luigi Aloj, Biagio Pecori, et al.Journal of Experimental & Clinical Cancer Research : CR|March 4, 2022
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulationMaria Serena Roca, Tania Moccia, Federica Iannelli, et al.Journal of Cellular Biochemistry|November 17, 2010
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cellsPaolo Grieco, Renato Franco, Giuseppina Bozzuto, et al.Cell Death & Disease|December 13, 2023
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, et al.Cell Death & Disease|August 1, 2025
Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancerMaria Serena Roca, Rita Lombardi, Cristina Testa, et al.International Journal of Oncology|November 6, 2007
The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomasRoberto Bei, Laura Masuelli, Paola Trono, et al.Pageof 16